8-K - Cue Biopharma, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Other Event

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

. Entry into a Material Definitive Agreement. On December 19, 2025, Cue Biopharma, Inc. (the “Company”) entered into an underwriting agreement (the “Underwritin

Material Agreement

$8.9M$10.3M

8.01

. Other Events. The full text of the press release announcing the pricing of the underwritten public offering on December 19, 2025 is attached as Exhibit 99.1 h

Other Event

$5.0M$5.0M

9.01

. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 1.1 Underwriting Agreement, dated December 19, 2025, by and between Cue Biopharma, Inc

Exhibits Only

Source Document

Exhibits (6)

1.1

EX-1.1

4.1

EX-4.1

4.2

EX-4.2

5.1

EX-5.1

8-K

99.1

EX-99.1